Associate Chief Physician, Doctor of Medicine With over 10 years of experience in the diagnosis and treatment of soft tissue tumors, retroperitoneal tumors, and hepatobiliary and pancreatic malignancies. Extensive clinical experience has been accumulated in surgical treatment, perioperative management, pharmacotherapy, and clinical trial treatments for the aforementioned diseases. Served as PI and Sub-I in multiple clinical studies targeting these conditions. Led several research projects, including the Capital Health Development Research Special Project, CSCO Clinical Oncology Research Fund, Peking University Cancer Hospital Interdisciplinary Research Fund, and Peking University Cancer Hospital Internal Fund. Obtained one invention patent (first inventor). Awarded "Best Debater" multiple times in debates on retroperitoneal soft tissue tumors and hepatobiliary and pancreatic malignancies. Published over 10 SCI papers in recent years. Published the following articles as first author (co-first author): 1. Wang Z, Wu JH, Lv A, Li CP, Tian XY, Hao CY. Anterior Approach to En Bloc Resection in Left-Sided Retroperitoneal Sarcoma with Adjacent Organ Involvement: A Study of 25 Patients in a Single Center. Med Sci Monit. 2018; 24:961-969. 2. Chengxue H, YanHui G, Nina Z, Zhen W, Teli L, Xiaoxia X, Feng W, Hua Z, Zhi Y, Xianteng Y, Lei X. Construction and Application of a PD-L1-Targeted Multimodal Diagnostic and Dual-Functional Theranostics Nanoprobes. Int J Nanomedicine. 2024; 19. 3. Wang Z, Wu J, Lv A, Tian X, Hao C. En bloc resection for intra-abdominal/retroperitoneal desmoid-type fibromatosis with adjacent organ involvement: A case series and literature review. Biosci Trends. 2018; 12:620-626. 4. Wang Z, Wu J, Lv A, Li C, Li Z, Zhao M, Hao C. Infiltration characteristics and influencing factors of retroperitoneal liposarcoma: Novel evidence for extended surgery and a tumor grading system. Biosci Trends. 2018; 12:185-192. 5. Yao Y, Wang Z, Yong L, Yao Q, Tian X, Wang T, Yang Q, Hao C, Zhou T. Longitudinal and time-to-event modeling for prognostic implications of radical surgery in retroperitoneal sarcoma. CPT Pharmacometrics Syst Pharmacol. 2022. 6. Wang Z, Wu JH, Li CP, Lv A, Qiu H, Tian XY, Liu BN, Hao CY. Patients with first recurrent retroperitoneal sarcoma that can be macroscopically completely resected can achieve comparable outcomes with that of primary patients after en bloc resection of tumor and adjacent organs. Front Surg. 2022; 9:956384. 7. Wang Z, Wu J, Tian X, Hao C. Targeted therapy of desmoid-type fibromatosis: mechanism, current situation, and future prospects. Front Med. 2019. 8. Lei X, Yan W, Yanan R, Zhen W, Nina Z, Wenyuan Z, Lixin Z, Ling J, Chengxue H, Xiangxi M, Hua Z, Zhi Y. A whole-body imaging technique for tumor-specific diagnostics and screening of B7-H3-targeted therapies. J Clin Invest. 2025.